$4.17
-0.015-0.36%
Last update: Dec 15, 2:40 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
CytomX Therapeutics Insider Trading Activity
CTMXNASDAQ
CytomX Therapeutics Insider Trading Activity | NASDAQ:CTMX | Benzinga
Track the latest CytomX Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for CytomX Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are CytomX Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On November 10, 2025, Sean A McCarthy, the company's CEO sold 101.79K shares for $4.54 each.
Ownership Statistics for CytomX Therapeutics Inc
Shares Outstanding
169.435M
Insider Shares Owned
2.388M
Insider Percentage Owned
1.41%
Institutional Shares Held
34.083M
Institutional Percentage Held
20.1%
| Nov 10, 2025 | Sean A McCarthy | CEO | -101.79K | $4.54 | -$461.91K | SELL | -8.61% | 1.08M | Nov 06 | View |
| Jun 17, 2025 | Christopher Ogden | CHIEF FINANCIAL OFFICER | 25.25K | $2.72 | -$33.38K | SELL-OPTIONS | 12.56% | 226.27K | Jun 13 - Jun 16 | View |
| Jun 17, 2025 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | 23.62K | $2.69 | -$37.33K | SELL-OPTIONS | 9.50% | 272.25K | Jun 13 - Jun 16 | View |
| Jun 17, 2025 | Sean A McCarthy | CEO | 94.49K | $2.69 | -$149.26K | SELL-OPTIONS | 8.68% | 1.18M | Jun 13 - Jun 16 | View |
| Mar 20, 2025 | Sean A McCarthy | CEO | -37.66K | $0.60 | -$22.56K | SELL | -3.34% | 1.09M | Mar 18 | View |
| Mar 20, 2025 | Christopher Ogden | CHIEF FINANCIAL OFFICER | -8.55K | $0.60 | -$5.12K | SELL | -4.08% | 201.03K | Mar 18 | View |
| Mar 20, 2025 | Yu-Waye Chu | CHIEF MEDICAL OFFICER | -4.03K | $0.60 | -$2.41K | SELL | -2.88% | 135.72K | Mar 18 | View |
| Mar 20, 2025 | Lloyd Rowland | GENERAL COUNSEL | -10.20K | $0.60 | -$6.11K | SELL | -7.80% | 120.59K | Mar 18 | View |
| Mar 20, 2025 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | -19.51K | $0.60 | -$11.69K | SELL | -7.28% | 248.64K | Mar 18 | View |
| Aug 22, 2024 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 6.14% | 122.24K | Aug 20 | View |
| Aug 22, 2024 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 4.19% | 175.65K | Aug 20 | View |
| Aug 22, 2024 | Lloyd Rowland | GENERAL COUNSEL | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 5.71% | 130.80K | Aug 20 | View |
| Aug 22, 2024 | Christopher Ogden | CHIEF FINANCIAL OFFICER | 4.89K | $1.23 | -$2.44K | SELL-OPTIONS | 4.74% | 108.08K | Aug 20 | View |
| Aug 22, 2024 | Sean A McCarthy | CEO | 23.60K | $1.23 | -$17.08K | SELL-OPTIONS | 3.24% | 751.01K | Aug 20 | View |
| Mar 21, 2024 | Lloyd Rowland | GENERAL COUNSEL | -5.27K | $2.09 | -$10.99K | SELL | -4.28% | 117.73K | Mar 19 | View |
| Mar 21, 2024 | Sean A McCarthy | CEO | -20.22K | $2.09 | -$42.18K | SELL | -3.17% | 617.64K | Mar 19 | View |
| Mar 21, 2024 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -2.97K | $2.09 | -$6.20K | SELL | -3.35% | 85.69K | Mar 19 | View |
| Mar 21, 2024 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | -12.79K | $2.09 | -$26.68K | SELL | -7.05% | 168.58K | Mar 19 | View |
| Mar 21, 2024 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | -6.56K | $2.09 | -$13.69K | SELL | -5.48% | 113.24K | Mar 19 | View |
| Dec 22, 2023 | Sean A McCarthy | CEO | -13.55K | $1.38 | -$18.71K | SELL | -2.41% | 547.86K | Dec 20 | View |
| Dec 22, 2023 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | -4.08K | $1.38 | -$5.63K | SELL | -2.56% | 155.12K | Dec 20 | View |
| Dec 22, 2023 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | -4.08K | $1.38 | -$5.63K | SELL | -4.34% | 89.80K | Dec 20 | View |
| Dec 22, 2023 | Lloyd Rowland | GENERAL COUNSEL | -4.08K | $1.38 | -$5.63K | SELL | -3.99% | 98.00K | Dec 20 | View |
| Dec 22, 2023 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -1.99K | $1.38 | -$2.75K | SELL | -3.93% | 48.66K | Dec 20 | View |
| Sep 22, 2023 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | 7.13K | $1.30 | -$5.36K | GRANT | 5.06% | 147.95K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | 7.13K | $1.30 | -$5.36K | GRANT | 9.85% | 79.56K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Sean A McCarthy | CEO | 25.40K | $1.30 | -$18.99K | GRANT | 5.09% | 523.91K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Lloyd Rowland | GENERAL COUNSEL | 9.51K | $1.30 | -$7.14K | GRANT | 13.38% | 80.61K | Sep 20 - Sep 22 | View |
| Mar 31, 2023 | Elaine V Jones | — | 5.00K | $1.55 | $7.75K | BUY | 3521.13% | 5.14K | Mar 29 | View |
| Mar 20, 2023 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -516.00 | $1.98 | -$1.02K | SELL | -1.35% | 37.77K | Mar 16 | View |
| Mar 20, 2023 | Carlos Campoy | CHIEF FINANCIAL OFFICER | -1.75K | $1.98 | -$3.46K | SELL | -4.37% | 38.22K | Mar 16 | View |
| Mar 20, 2023 | Sean A McCarthy | CEO | -7.12K | $1.88 | -$13.39K | SELL | -1.46% | 481.98K | Mar 16 | View |
| Mar 20, 2023 | Lloyd Rowland | GENERAL COUNSEL | -2.04K | $1.98 | -$4.03K | SELL | -2.79% | 71.09K | Mar 16 | View |
| Mar 20, 2023 | Jeffrey B Landau | CHIEF FINANCIAL OFFICER | -1.48K | $1.98 | -$2.92K | SELL | -2.00% | 72.43K | Mar 16 | View |
| Mar 20, 2023 | Amy C Peterson | EVP, CHIEF DEVELOPMENT OFFICER | -4.26K | $1.98 | -$8.42K | SELL | -6.79% | 58.43K | Mar 16 | View |
| Jul 21, 2022 | Amy C Peterson | EVP, CHIEF DEVELOPMENT OFFICER | 12.54K | $1.42 | -$10.61K | GRANT | 25.00% | 62.69K | Jul 19 - Jul 20 | View |
| Jul 21, 2022 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | 7.04K | $1.42 | -$5.98K | GRANT | 26.22% | 33.91K | Jul 19 - Jul 20 | View |
| Jul 21, 2022 | Sean A McCarthy | PRESIDENT AND CEO | 25.09K | $1.42 | -$21.21K | GRANT | 6.99% | 384.10K | Jul 19 - Jul 20 | View |
| Jul 21, 2022 | Lloyd Rowland | GENERAL COUNSEL | 9.40K | $1.42 | -$7.97K | GRANT | 27.41% | 43.69K | Jul 19 - Jul 20 | View |
| Jul 21, 2022 | Alison L Hannah | CHIEF MEDICAL OFFICER | 9.40K | $1.42 | -$7.97K | GRANT | 41.77% | 31.90K | Jul 19 - Jul 20 | View |
| Jul 21, 2022 | Carlos Campoy | CHIEF FINANCIAL OFFICER | 11.05K | $1.42 | -$5.62K | GRANT | 38.21% | 39.97K | Jul 19 - Jul 20 | View |
| Jun 21, 2021 | Sean A McCarthy | PRESIDENT AND CEO | -100.00K | $7.04 | -$704.47K | SELL | -49.76% | 100.97K | Jun 16 | View |
| Apr 02, 2021 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $4.31 | -$636.08K | SELL-OPTIONS | 0.00% | 206.89K | Mar 31 | View |
| May 14, 2020 | Sean A McCarthy | — | 0.00 | $8.07 | -$499.18K | OPTION EXERCISE | 0.00% | 84.31K | May 12 | View |
| Mar 05, 2019 | Lloyd Rowland | GENERAL COUNSEL | 9.00K | $10.33 | $92.97K | BUY | 919.31% | 9.98K | Mar 04 | View |
| Dec 14, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $8.22 | -$40.65K | SELL-OPTIONS | 0.00% | 5.93K | Dec 12 | View |
| Nov 05, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $8.22 | -$40.65K | SELL-OPTIONS | 0.00% | 5.93K | Nov 01 | View |
| Nov 05, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $8.29 | -$87.62K | SELL-OPTIONS | 0.00% | 82.06K | Nov 01 - Nov 02 | View |
| Oct 02, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $9.95 | -$51.03K | SELL-OPTIONS | 0.00% | 5.93K | Oct 01 | View |
| Sep 06, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $11.92 | -$62.82K | SELL-OPTIONS | 0.00% | 5.93K | Sep 04 | View |
| Sep 06, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $11.72 | -$264.79K | SELL-OPTIONS | 0.00% | 82.06K | Sep 04 | View |
| Aug 02, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $13.66 | -$74.32K | SELL-OPTIONS | 0.00% | 5.93K | Aug 01 | View |
| Jul 09, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $13.32 | -$105.61K | SELL-OPTIONS | 0.00% | 82.06K | Jul 05 | View |
| Jul 06, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $13.33 | -$47.69K | SELL-OPTIONS | 0.00% | 82.06K | Jul 03 | View |
| Jul 03, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $11.91 | -$63.90K | SELL-OPTIONS | 0.00% | 5.93K | Jul 02 | View |
| Jul 03, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $12.50 | -$285.15K | SELL-OPTIONS | 0.00% | 82.06K | Jul 02 | View |
| Jun 05, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 1.19K | $15.95 | -$52.76K | SELL-OPTIONS | 25.04% | 5.93K | May 31 - Jun 01 | View |
| May 02, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $13.89 | -$75.78K | SELL-OPTIONS | 0.00% | 4.74K | May 01 | View |
| May 02, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $14.06 | -$488.91K | SELL-OPTIONS | 0.00% | 158.88K | May 01 | View |
| Apr 04, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $14.69 | -$80.58K | SELL-OPTIONS | 0.00% | 4.74K | Apr 02 | View |
| Mar 27, 2018 | Frederick W Gluck | DIRECTOR | -5.00K | $31.93 | -$159.64K | SELL | -1.79% | 274.84K | Mar 26 | View |
| Mar 05, 2018 | Frederick W Gluck | DIRECTOR | -16.18K | $30.00 | -$485.47K | SELL | -5.47% | 279.84K | Mar 02 | View |
| Mar 05, 2018 | Rachel Humphrey | CHIEF MEDICAL OFFICER | 0.00 | $18.31 | -$377.91K | SELL-OPTIONS | 0.00% | 30.23K | Mar 02 | View |
| Mar 05, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | 0.00 | $15.60 | -$949.94K | SELL-OPTIONS | 0.00% | 4.74K | Mar 01 - Mar 02 | View |
| Mar 05, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $15.40 | -$549.32K | SELL-OPTIONS | 0.00% | 158.88K | Mar 01 | View |
| Mar 02, 2018 | Rachel Humphrey | CHIEF MEDICAL OFFICER | 0.00 | $18.31 | -$557.51K | SELL-OPTIONS | 0.00% | 30.23K | Feb 28 | View |
| Mar 02, 2018 | Frederick W Gluck | DIRECTOR | -3.82K | $30.00 | -$114.57K | SELL | -1.27% | 296.02K | Feb 28 | View |
| Feb 02, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.55K | $26.69 | -$68.01K | SELL | -34.96% | 4.74K | Feb 01 | View |
| Jan 09, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $13.07 | -$155.82K | SELL-OPTIONS | 0.00% | 163.38K | Jan 05 | View |
| Jan 08, 2018 | Frederick W Gluck | DIRECTOR | -10.00K | $25.01 | -$250.08K | SELL | -3.23% | 299.84K | Jan 05 | View |
| Jan 04, 2018 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $11.09 | -$259.81K | SELL-OPTIONS | 0.00% | 163.38K | Jan 02 | View |
| Jan 03, 2018 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $21.11 | -$52.77K | SELL | -25.54% | 7.29K | Jan 02 | View |
| Dec 28, 2017 | Frederick W Gluck | DIRECTOR | -5.00K | $22.29 | -$111.43K | SELL | -1.59% | 309.84K | Dec 26 | View |
| Dec 05, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.34K | $16.36 | -$49.47K | SELL | -19.27% | 9.79K | Nov 30 - Dec 01 | View |
| Dec 05, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 398.00 | $10.99 | -$275.08K | SELL-OPTIONS | 0.24% | 163.38K | Nov 30 - Dec 01 | View |
| Nov 03, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $10.40 | -$271.28K | SELL-OPTIONS | 0.00% | 162.98K | Nov 01 | View |
| Nov 03, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $20.00 | -$50.00K | SELL | -17.09% | 12.13K | Nov 01 | View |
| Oct 06, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $12.54 | -$443.30K | SELL-OPTIONS | 0.00% | 162.98K | Oct 04 | View |
| Oct 06, 2017 | Michael Kavanaugh | CSO, HEAD RES.&NON-CLIN. DEV. | 0.00 | $14.41 | -$960.94K | SELL-OPTIONS | 0.00% | 13.92K | Oct 04 | View |
| Oct 06, 2017 | Frederick W Gluck | DIRECTOR | -10.00K | $24.27 | -$242.68K | SELL | -3.08% | 314.84K | Oct 04 | View |
| Oct 04, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $9.76 | -$168.53K | SELL-OPTIONS | 0.00% | 162.98K | Oct 02 | View |
| Oct 04, 2017 | Robert I Tepper | 10% OWNER | -24.78K | $24.34 | -$603.07K | SELL | -0.57% | 4.35M | Oct 04 | View |
| Oct 04, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $18.10 | -$45.25K | SELL | -14.60% | 14.63K | Oct 02 | View |
| Sep 27, 2017 | Frederick W Gluck | DIRECTOR | -5.00K | $17.30 | -$86.48K | SELL | -1.52% | 324.84K | Sep 26 | View |
| Sep 21, 2017 | Robert I Tepper | 10% OWNER | -20.00K | $18.00 | -$360.00K | SELL | -0.46% | 4.37M | Sep 19 | View |
| Sep 05, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $17.17 | -$42.93K | SELL | -12.74% | 17.13K | Sep 01 | View |
| Sep 05, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $9.13 | -$162.60K | SELL-OPTIONS | 0.00% | 162.98K | Sep 01 | View |
| Sep 01, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $9.22 | -$310.54K | SELL-OPTIONS | 0.00% | 162.98K | Aug 31 | View |
| Aug 11, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $15.00 | -$37.50K | SELL | -11.30% | 19.63K | Aug 09 | View |
| Aug 11, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $7.97 | -$67.20K | SELL-OPTIONS | 0.00% | 162.98K | Aug 09 | View |
| Jul 06, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $8.23 | -$69.68K | SELL-OPTIONS | 0.00% | 162.98K | Jul 03 | View |
| Jul 06, 2017 | Debanjan Ray | CHIEF FINANCIAL OFFICER | -2.50K | $15.47 | -$38.67K | SELL | -10.15% | 22.13K | Jul 03 | View |
| Jun 30, 2017 | Robert I Tepper | 10% OWNER | -15.00K | $16.00 | -$240.00K | SELL | -0.29% | 5.22M | Jun 29 | View |
| Jun 27, 2017 | Frederick W Gluck | DIRECTOR | -5.00K | $14.61 | -$73.05K | SELL | -1.49% | 329.84K | Jun 26 | View |
| Jun 27, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 8.96K | $7.97 | $71.45K | SELL-OPTIONS | 5.82% | 162.98K | Jun 26 | View |
| Jun 06, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $7.97 | -$4.22K | SELL-OPTIONS | 0.00% | 162.98K | Jun 05 | View |
| May 02, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $8.32 | -$70.54K | SELL-OPTIONS | 0.00% | 160.72K | May 01 | View |
| Apr 14, 2017 | Kevin Starr | 10% OWNER | -28.36K | $16.36 | -$463.79K | SELL | -0.54% | 5.20M | Apr 12 | View |
| Apr 05, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $9.08 | -$155.62K | SELL-OPTIONS | 0.00% | 160.72K | Apr 03 - Apr 04 | View |
| Mar 27, 2017 | THIRD ROCK VENTURES LPThird Rock Ventures GP LPTRV GP LLCMARK LEVINKEVIN STARRROBERT TEPPER | 10% OWNER | -1.65M | $17.39 | -$28.70M | SELL | -23.98% | 5.23M | Mar 23 - Mar 27 | View |
| Mar 27, 2017 | Neil Exter | DIRECTOR | 0.00 | $0.00 | $0.00 | s | 0.00% | 11.20K | Mar 23 - Mar 27 | View |
| Mar 21, 2017 | Robert C. Goeltz II | CHIEF FINANCIAL OFFICER | 0.00 | $12.14 | -$330.10K | SELL-OPTIONS | 0.00% | 9.79K | Mar 20 | View |
| Mar 21, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $10.27 | -$267.57K | SELL-OPTIONS | 0.00% | 160.72K | Mar 20 | View |
| Mar 03, 2017 | Sean A McCarthy | PRESIDENT AND CEO | 0.00 | $8.07 | -$198.88K | SELL-OPTIONS | 0.00% | 160.72K | Mar 03 | View |
| Dec 01, 2016 | Timothy Shannon | DIRECTOR | -22.09K | $11.18 | -$247.01K | SELL | -0.68% | 3.24M | Nov 29 | View |
| Dec 01, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -422.09K | $11.18 | -$247.01K | SELL | -11.51% | 3.24M | Nov 29 - Nov 30 | View |
| Nov 28, 2016 | Timothy Shannon | DIRECTOR | -38.46K | $11.56 | -$444.40K | SELL | -1.04% | 3.67M | Nov 23 - Nov 28 | View |
| Nov 28, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -38.46K | $11.56 | -$444.40K | SELL | -1.04% | 3.67M | Nov 23 - Nov 28 | View |
| Nov 22, 2016 | Timothy M Shannon | DIRECTOR | -42.55K | $11.71 | -$498.08K | SELL | -1.14% | 3.71M | Nov 22 | View |
| Nov 22, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -42.55K | $11.71 | -$498.08K | SELL | -1.14% | 3.70M | Nov 22 | View |
| Nov 21, 2016 | Timothy M Shannon | DIRECTOR | -45.32K | $11.61 | -$526.09K | SELL | -1.19% | 3.75M | Nov 17 - Nov 21 | View |
| Nov 21, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -45.32K | $11.61 | -$526.09K | SELL | -1.20% | 3.75M | Nov 17 - Nov 21 | View |
| Nov 16, 2016 | Timothy Shannon | DIRECTOR | -51.58K | $11.50 | -$593.43K | SELL | -1.34% | 3.79M | Nov 15 - Nov 16 | View |
| Nov 16, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -51.58K | $11.50 | -$593.43K | SELL | -1.34% | 3.79M | Nov 15 - Nov 16 | View |
| Nov 14, 2016 | Timothy Shannon | DIRECTOR | -86.27K | $11.16 | -$962.91K | SELL | -2.19% | 3.84M | Nov 10 - Nov 14 | View |
| Nov 14, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -86.27K | $11.16 | -$962.91K | SELL | -2.19% | 3.84M | Nov 10 - Nov 14 | View |
| Nov 10, 2016 | Timothy Shannon | DIRECTOR | -13.73K | $11.03 | -$151.50K | SELL | -0.35% | 3.93M | Nov 09 | View |
| Nov 10, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -13.73K | $11.03 | -$151.50K | SELL | -0.35% | 3.93M | Nov 09 | View |
| Jun 10, 2016 | TIMOTHY SHANNON | DIRECTOR | -48.43K | $10.07 | -$487.50K | SELL | -1.13% | 4.24M | Jun 08 - Jun 10 | View |
| Jun 10, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -48.43K | $10.07 | -$487.50K | SELL | -1.13% | 4.24M | Jun 08 - Jun 10 | View |
| Jun 08, 2016 | TIMOTHY SHANNON | DIRECTOR | -111.50K | $10.01 | -$1.12M | SELL | -2.53% | 4.29M | Jun 06 - Jun 07 | View |
| Jun 08, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -111.50K | $10.01 | -$1.12M | SELL | -2.53% | 4.29M | Jun 06 - Jun 07 | View |
| Jun 06, 2016 | TIMOTHY SHANNON | DIRECTOR | -59.62K | $10.80 | -$644.05K | SELL | -1.34% | 4.40M | Jun 02 - Jun 03 | View |
| Jun 06, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -59.62K | $10.80 | -$644.05K | SELL | -1.34% | 4.40M | Jun 02 - Jun 03 | View |
| Jun 02, 2016 | TIMOTHY SHANNON | DIRECTOR | -22.46K | $10.75 | -$241.48K | SELL | -0.50% | 4.46M | Jun 01 | View |
| Jun 02, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -22.46K | $10.75 | -$241.48K | SELL | -0.50% | 4.46M | Jun 01 | View |
| Jun 01, 2016 | TIMOTHY SHANNON | DIRECTOR | -25.08K | $10.60 | -$265.87K | SELL | -0.56% | 4.49M | May 27 | View |
| Jun 01, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -25.08K | $10.60 | -$265.87K | SELL | -0.56% | 4.49M | May 27 | View |
| May 27, 2016 | TIMOTHY SHANNON | DIRECTOR | -51.34K | $10.34 | -$530.81K | SELL | -1.13% | 4.51M | May 25 - May 26 | View |
| May 27, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -51.34K | $10.34 | -$530.81K | SELL | -1.13% | 4.51M | May 25 - May 26 | View |
| May 25, 2016 | TIMOTHY SHANNON | — | -13.25K | $10.09 | -$133.74K | SELL | -0.29% | 4.56M | May 23 - May 24 | View |
| May 25, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -13.25K | $10.09 | -$133.74K | SELL | -0.29% | 4.56M | May 23 - May 24 | View |
| May 23, 2016 | TIMOTHY SHANNON | — | -8.69K | $10.10 | -$87.78K | SELL | -0.19% | 4.58M | May 19 - May 20 | View |
| May 23, 2016 | Canaan IX LPCanaan Partners IX LLC | DIRECTOR | -8.69K | $10.10 | -$87.78K | SELL | -0.19% | 4.58M | May 19 - May 20 | View |
| Oct 16, 2015 | Cynthia J Ladd | SENIOR VP AND GENERAL COUNSEL | 3.00K | $12.00 | $36.00K | BUY | ∞ | 3.00K | Oct 14 | View |
| Oct 16, 2015 | Michael William Kavanaugh | CSO, HEAD RES.&NON-CLIN. DEV. | 5.00K | $12.00 | $60.00K | BUY | ∞ | 5.00K | Oct 14 | View |
| Oct 16, 2015 | FREDERICK GLUCK | DIRECTOR | 15.00K | $12.00 | $180.00K | BUY | ∞ | 8.20K | Oct 14 | View |
| Oct 14, 2015 | James FlynnDeerfield Mgmt LPCO MANAGEMENT DEERFIELDDeerfield Special Situations Fund LPDeerfield Mgmt III LPDeerfield Private Design Fund III LP | 10% OWNER | 946.02K | $12.00 | $7.50M | BUY | ∞ | 275.00K | Oct 14 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
CTMX Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved